BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oberg JA, Glade Bender JL, Sulis ML, Pendrick D, Sireci AN, Hsiao SJ, Turk AT, Dela Cruz FS, Hibshoosh H, Remotti H, Zylber RJ, Pang J, Diolaiti D, Koval C, Andrews SJ, Garvin JH, Yamashiro DJ, Chung WK, Emerson SG, Nagy PL, Mansukhani MM, Kung AL. Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations. Genome Med 2016;8:133. [PMID: 28007021 DOI: 10.1186/s13073-016-0389-6] [Cited by in Crossref: 81] [Cited by in F6Publishing: 77] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Jones DTW, Banito A, Grünewald TGP, Haber M, Jäger N, Kool M, Milde T, Molenaar JJ, Nabbi A, Pugh TJ, Schleiermacher G, Smith MA, Westermann F, Pfister SM. Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours. Nat Rev Cancer 2019;19:420-38. [DOI: 10.1038/s41568-019-0169-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
2 Summers RJ, Castellino SM, Porter CC, MacDonald TJ, Basu GD, Szelinger S, Bhasin MK, Cash T, Carter AB, Castellino RC, Fangusaro JR, Mitchell SG, Pauly MG, Pencheva B, Wechsler DS, Graham DK, Goldsmith KC. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care. JCO Precis Oncol 2022;6:e2100451. [PMID: 35544730 DOI: 10.1200/PO.21.00451] [Reference Citation Analysis]
3 Takaoka K, Kawazu M, Koya J, Yoshimi A, Masamoto Y, Maki H, Toya T, Kobayashi T, Nannya Y, Arai S, Ueno T, Ueno H, Suzuki K, Harada H, Manabe A, Hayashi Y, Mano H, Kurokawa M. A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination. Leukemia 2019;33:1773-82. [PMID: 30696947 DOI: 10.1038/s41375-019-0385-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
4 Lee YJ, Kim D, Kim HS, Na K, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT. Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer. Yonsei Med J 2019;60:914-23. [PMID: 31538426 DOI: 10.3349/ymj.2019.60.10.914] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Motzer RJ, Robbins PB, Powles T, Albiges L, Haanen JB, Larkin J, Mu XJ, Ching KA, Uemura M, Pal SK, Alekseev B, Gravis G, Campbell MT, Penkov K, Lee JL, Hariharan S, Wang X, Zhang W, Wang J, Chudnovsky A, di Pietro A, Donahue AC, Choueiri TK. Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. Nat Med 2020;26:1733-41. [PMID: 32895571 DOI: 10.1038/s41591-020-1044-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 22.5] [Reference Citation Analysis]
6 Pendrick DM, Oberg JA, Hsiao SJ, Chung WK, Koval C, Sireci A, Kuo JH, Satwani P, Glasser CL, Sulis ML, Mansukhani MM, Glade Bender JL. Identification of a secondary RET mutation in a pediatric patient with relapsed acute myeloid leukemia leads to the diagnosis and treatment of asymptomatic metastatic medullary thyroid cancer in a parent: a case for sequencing the germline. Cold Spring Harb Mol Case Stud 2019;5:a003889. [PMID: 30936199 DOI: 10.1101/mcs.a003889] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Goudie C, Hannah-Shmouni F, Kavak M, Stratakis CA, Foulkes WD. 65 YEARS OF THE DOUBLE HELIX: Endocrine tumour syndromes in children and adolescents. Endocr Relat Cancer 2018;25:T221-44. [PMID: 29986924 DOI: 10.1530/ERC-18-0160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Langenberg KPS, Looze EJ, Molenaar JJ. The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial Development. Cancers (Basel) 2021;13:4324. [PMID: 34503139 DOI: 10.3390/cancers13174324] [Reference Citation Analysis]
9 Pikman Y, Stegmaier K. Targeted therapy for fusion-driven high-risk acute leukemia. Blood 2018;132:1241-7. [PMID: 30049809 DOI: 10.1182/blood-2018-04-784157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
10 Juarez OA, Pencheva BB, Bellcross C, Schneider KW, Turner J, Porter CC. Cancer genetic counseling for childhood cancer predisposition is associated with improved levels of knowledge and high satisfaction in parents. J Genet Couns 2021;30:710-9. [PMID: 33179831 DOI: 10.1002/jgc4.1357] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Tsimberidou AM, Fountzilas E, Bleris L, Kurzrock R. Transcriptomics and solid tumors: The next frontier in precision cancer medicine. Semin Cancer Biol 2020:S1044-579X(20)30196-6. [PMID: 32950605 DOI: 10.1016/j.semcancer.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Barsan V, Paul M, Gorsi H, Malicki D, Elster J, Kuo DJ, Crawford J. Clinical Impact of Next-generation Sequencing in Pediatric Neuro-Oncology Patients: A Single-institutional Experience. Cureus 2019;11:e6281. [PMID: 31827999 DOI: 10.7759/cureus.6281] [Reference Citation Analysis]
13 Kraft IL, Godley LA. Identifying potential germline variants from sequencing hematopoietic malignancies. Hematology Am Soc Hematol Educ Program 2020;2020:219-27. [PMID: 33275754 DOI: 10.1182/hematology.2020006910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fiala EM, Jayakumaran G, Mauguen A, Kennedy JA, Bouvier N, Kemel Y, Fleischut MH, Maio A, Salo-Mullen EE, Sheehan M, Arnold AG, Latham A, Carlo MI, Cadoo K, Murkherjee S, Slotkin EK, Trippett T, Bender JG, Meyers PA, Wexler L, Dela Cruz FS, Cheung NK, Basu E, Kentsis A, Ortiz M, Francis JH, Dunkel IJ, Khakoo Y, Gilheeney S, Sait SF, Forlenza CJ, Sulis M, Karajannis M, Modak S, Gerstle JT, Heaton TE, Roberts S, Yang C, Jairam S, Vijai J, Topka S, Friedman DN, Stadler ZK, Robson M, Berger MF, Schultz N, Ladanyi M, O'Reilly RJ, Abramson DH, Ceyhan-Birsoy O, Zhang L, Mandelker D, Shukla NN, Kung AL, Offit K, Zehir A, Walsh MF. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nat Cancer 2021;2:357-65. [PMID: 34308366 DOI: 10.1038/s43018-021-00172-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Forrest SJ, Geoerger B, Janeway KA. Precision medicine in pediatric oncology. Curr Opin Pediatr 2018;30:17-24. [PMID: 29189430 DOI: 10.1097/MOP.0000000000000570] [Cited by in Crossref: 47] [Cited by in F6Publishing: 22] [Article Influence: 11.8] [Reference Citation Analysis]
16 Vo KT, Parsons DW, Seibel NL. Precision Medicine in Pediatric Oncology. Surg Oncol Clin N Am 2020;29:63-72. [PMID: 31757314 DOI: 10.1016/j.soc.2019.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Witjes L, Van Troys M, Verhasselt B, Ampe C. Prevalence of Cytoplasmic Actin Mutations in Diffuse Large B-Cell Lymphoma and Multiple Myeloma: A Functional Assessment Based on Actin Three-Dimensional Structures. Int J Mol Sci 2020;21:E3093. [PMID: 32349449 DOI: 10.3390/ijms21093093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sylvester DE, Chen Y, Jamieson RV, Dalla-Pozza L, Byrne JA. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature. J Med Genet 2018;55:785-93. [PMID: 30287599 DOI: 10.1136/jmedgenet-2018-105488] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Melloy PG. The anaphase-promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer. Genes Chromosomes Cancer 2020;59:189-202. [PMID: 31652364 DOI: 10.1002/gcc.22820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Xu-Monette ZY, Zhang H, Zhu F, Tzankov A, Bhagat G, Visco C, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, You H, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Parsons BM, van Krieken JH, Piris MA, Winter JN, Hagemeister FB, Shahbaba B, De Dios I, Zhang H, Li Y, Xu B, Albitar M, Young KH. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Adv 2020;4:3391-404. [PMID: 32722783 DOI: 10.1182/bloodadvances.2020001949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Yeldell SB, Yang L, Lee J, Eberwine JH, Dmochowski IJ. Oligonucleotide Probe for Transcriptome in Vivo Analysis (TIVA) of Single Neurons with Minimal Background. ACS Chem Biol 2020;15:2714-21. [PMID: 32902259 DOI: 10.1021/acschembio.0c00499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
22 Walsh MF, Ritter DI, Kesserwan C, Sonkin D, Chakravarty D, Chao E, Ghosh R, Kemel Y, Wu G, Lee K, Kulkarni S, Hedges D, Mandelker D, Ceyhan-Birsoy O, Luo M, Drazer M, Zhang L, Offit K, Plon SE. Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes. Hum Mutat 2018;39:1542-52. [PMID: 30311369 DOI: 10.1002/humu.23640] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
23 Fazlollahi L, Hsiao SJ, Kochhar M, Mansukhani MM, Yamashiro DJ, Remotti HE. Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma. Cancers (Basel) 2019;11:E1992. [PMID: 31835848 DOI: 10.3390/cancers11121992] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Ri M, Handa H, Ishida T, Shibayama H, Abe M, Iriyama C, Karube K, Nishikori M, Ohshima K, Kataoka K, Yoshida K, Shiraishi Y, Goto H, Adachi S, Kobayashi R, Kiyoi H, Miyazaki Y, Ogawa S, Kurahashi H, Yokoyama H, Manabe A, Iida S, Tomita A, Horibe K. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. Cancer Sci 2020;111:3367-78. [PMID: 32619037 DOI: 10.1111/cas.14552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Juan Ribelles A, Gargallo P, Berlanga P, Segura V, Yáñez Y, Juan B, Salom M, Llavador M, Font de Mora J, Castel V, Cañete A. Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas. J Pers Med 2021;11:268. [PMID: 33916788 DOI: 10.3390/jpm11040268] [Reference Citation Analysis]
26 Choi E, Park SJ, Lee G, Yoon SK, Lee M, Lee SK. The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma. Int J Mol Sci 2021;22:3284. [PMID: 33807071 DOI: 10.3390/ijms22063284] [Reference Citation Analysis]
27 Mora A, Bosch R, Cuellar-García C, Blanco L, Sierra J, Nomdedeu J, Moreno C. Gene expression workflow to analyze residual leukemic cells in Chronic Lymphocytic Leukemia. Int J Lab Hematol 2020;42:423-30. [PMID: 32333638 DOI: 10.1111/ijlh.13215] [Reference Citation Analysis]
28 Chen Y, Cruz FD, Sandhu R, Kung AL, Mundi P, Deasy JO, Tannenbaum A. Pediatric Sarcoma Data Forms a Unique Cluster Measured via the Earth Mover's Distance. Sci Rep 2017;7:7035. [PMID: 28765612 DOI: 10.1038/s41598-017-07551-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
29 Ni Chin WH, Li Z, Jiang N, Lim EH, Suang Lim JY, Lu Y, Chiew KH, Yin Kham SK, Zhi Oh BL, Tan AM, Ariffin H, Yang JJ, Eng-Juh Yeoh A. Practical Considerations for Using RNA Sequencing in Management of B-Cell Acute Lymphoblastic Leukemia: Malaysia-Singapore Acute Lymphoblastic Leukemia-Sequencing 2020 Implementation Strategy. J Mol Diagn 2021:S1525-1578(21)00237-3. [PMID: 34365011 DOI: 10.1016/j.jmoldx.2021.07.013] [Reference Citation Analysis]
30 Elfatih A, Mifsud B, Syed N, Badii R, Mbarek H, Abbaszadeh F, Estivill X; Qatar Genome Program Research Consortium. Actionable genomic variants in 6045 participants from the Qatar Genome Program. Hum Mutat 2021. [PMID: 34428338 DOI: 10.1002/humu.24278] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Tirtei E, Cereda M, De Luna E, Quarello P, Asaftei SD, Fagioli F. Omic approaches to pediatric bone sarcomas. Pediatr Blood Cancer 2020;67:e28072. [PMID: 31736201 DOI: 10.1002/pbc.28072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
32 Wouters RHP, van der Graaf R, Rigter T, Bunnik EM, Ploem MC, de Wert GMWR, Dondorp WJ, Cornel MC, Bredenoord AL. Towards a Responsible Transition to Learning Healthcare Systems in Precision Medicine: Ethical Points to Consider. J Pers Med 2021;11:539. [PMID: 34200580 DOI: 10.3390/jpm11060539] [Reference Citation Analysis]
33 Demirsoy U, Corapcioglu F. Clinical practice of a genetics referral selection tool in pediatric cancer patients. Eur J Med Genet 2021;64:104167. [PMID: 33588069 DOI: 10.1016/j.ejmg.2021.104167] [Reference Citation Analysis]
34 Wise-Oringer BK, Zanazzi GJ, Gordon RJ, Wardlaw SL, William C, Anyane-Yeboa K, Chung WK, Kohn B, Wisoff JH, David R, Oberfield SE. Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother. J Clin Endocrinol Metab 2019;104:4667-75. [PMID: 31166600 DOI: 10.1210/jc.2019-00817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
35 Poonnen PJ, Duffy JE, Hintze B, Shukla M, Brettin TS, Conrad NR, Yoo H, Guertin C, Looney JA, Vashistha V, Kelley MJ, Spector NL. Genomic Analysis of Metastatic Solid Tumors in Veterans: Findings From the VHA National Precision Oncology Program. JCO Precis Oncol 2019;3:PO. [PMID: 32914016 DOI: 10.1200/PO.19.00075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Singer F, Irmisch A, Toussaint NC, Grob L, Singer J, Thurnherr T, Beerenwinkel N, Levesque MP, Dummer R, Quagliata L, Rothschild SI, Wicki A, Beisel C, Stekhoven DJ. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics. BMC Med Inform Decis Mak 2018;18:89. [PMID: 30373609 DOI: 10.1186/s12911-018-0680-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
37 Oberg JA, Ruiz J, Ali-Shaw T, Schlechtweg KA, Ricci A, Kung AL, Chung WK, Appelbaum PS, Glade Bender JL, Levine JM. Whole-Genome and Whole-Exome Sequencing in Pediatric Oncology: An Assessment of Parent and Young Adult Patient Knowledge, Attitudes, and Expectations. JCO Precis Oncol 2018;2:PO. [PMID: 32913997 DOI: 10.1200/PO.17.00104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Marks LJ, Oberg JA, Pendrick D, Sireci AN, Glasser C, Coval C, Zylber RJ, Chung WK, Pang J, Turk AT, Hsiao SJ, Mansukhani MM, Glade Bender JL, Kung AL, Sulis ML. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience. Front Pediatr 2017;5:265. [PMID: 29312904 DOI: 10.3389/fped.2017.00265] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
39 Sabnis HS, Shulman DS, Mizukawa B, Bouvier N, Zehir A, Fangusaro J, Fabrizio VA, Whitlow C, Winchester M, Agresta L, Turpin B, Wechsler DS, DuBois SG, Glade-Bender J, Castellino SM, Shukla N. Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms. J Clin Oncol 2021;:JCO2101213. [PMID: 34591650 DOI: 10.1200/JCO.21.01213] [Reference Citation Analysis]
40 Janeway KA. Molecular profiling in the clinic: Moving from feasibility assessment to evaluating clinical impact. Pediatr Blood Cancer 2017;64. [PMID: 28233398 DOI: 10.1002/pbc.26482] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
41 Begum R. A decade of Genome Medicine: toward precision medicine. Genome Med 2019;11:13. [PMID: 30819206 DOI: 10.1186/s13073-019-0624-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
42 Perales Palacios I, García Campos F, Michaus Oquiñena L, Blanco Guzmán S, Lantero Benedito M. [Isolation of Plesiomonas shigelloides in a case of gastroenteritis]. Rev Clin Esp 1983;171:115-7. [PMID: 6658089 [PMID: 6658089 DOI: 10.1038/s41571-018-0002-6] [Cited by in Crossref: 125] [Cited by in F6Publishing: 119] [Article Influence: 3.3] [Reference Citation Analysis]
43 Yang HT, Shah RH, Tegay D, Onel K. Precision oncology: lessons learned and challenges for the future. Cancer Manag Res 2019;11:7525-36. [PMID: 31616176 DOI: 10.2147/CMAR.S201326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
44 Segura MF, Soriano A, Roma J, Piskareva O, Jiménez C, Boloix A, Fletcher JI, Haber M, Gray JC, Cerdá-Alberich L, Martínez de Las Heras B, Cañete A, Gallego S, Moreno L. Methodological advances in the discovery of novel neuroblastoma therapeutics. Expert Opin Drug Discov 2021;:1-13. [PMID: 34807782 DOI: 10.1080/17460441.2022.2002297] [Reference Citation Analysis]
45 Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown PA, Gossai N, McNeer JL, Shukla NN, Cole PD, Kahn JM, Chen J, Barth MJ, Magee JA, Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic A, Tognon CE, Patel T, Faust HL, Contreras CF, Cremer A, Cortopassi WA, Garrido Ruiz D, Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier K. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer Discov 2021;11:1424-39. [PMID: 33563661 DOI: 10.1158/2159-8290.CD-20-0564] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Hiemenz MC, Ostrow DG, Busse TM, Buckley J, Maglinte DT, Bootwalla M, Done J, Ji J, Raca G, Ryutov A, Xu X, Zhen CJ, Conroy JM, Hazard FK, Deignan JL, Rogers BB, Treece AL, Parham DM, Gai X, Judkins AR, Triche TJ, Biegel JA. OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies. J Mol Diagn 2018;20:765-76. [PMID: 30138724 DOI: 10.1016/j.jmoldx.2018.06.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
47 Khater F, Vairy S, Langlois S, Dumoucel S, Sontag T, St-Onge P, Bittencourt H, Dal Soglio D, Champagne J, Duval M, Leclerc JM, Laverdiere C, Tran TH, Patey N, Ellezam B, Perreault S, Piché N, Samson Y, Teira P, Jabado N, Michon B, Brossard J, Marzouki M, Cellot S, Sinnett D. Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers. JAMA Netw Open 2019;2:e192906. [PMID: 31026031 DOI: 10.1001/jamanetworkopen.2019.2906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
48 Cahaney C, Dhir A, Ghosh T. Role of Precision Medicine in Pediatric Oncology. Pediatr Ann 2022;51:e8-e14. [PMID: 35020508 DOI: 10.3928/19382359-20211209-01] [Reference Citation Analysis]
49 Lyudovyk O, Shen Y, Tatonetti NP, Hsiao SJ, Mansukhani MM, Weng C. Pathway analysis of genomic pathology tests for prognostic cancer subtyping. J Biomed Inform 2019;98:103286. [PMID: 31499184 DOI: 10.1016/j.jbi.2019.103286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Sylvester DE, Chen Y, Grima N, Saletta F, Padhye B, Bennetts B, Wright D, Krivanek M, Graf N, Zhou L, Catchpoole D, Kirk J, Latchoumanin O, Qiao L, Ballinger M, Thomas D, Jamieson R, Dalla-Pozza L, Byrne JA. Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer. Genes Chromosomes Cancer 2021. [PMID: 34687117 DOI: 10.1002/gcc.23006] [Reference Citation Analysis]
51 Cremers S, Aronson JK. Drugs for rare disorders. Br J Clin Pharmacol 2017;83:1607-13. [PMID: 28653488 DOI: 10.1111/bcp.13331] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
52 Cieślik M, Chinnaiyan AM. Cancer transcriptome profiling at the juncture of clinical translation. Nat Rev Genet 2018;19:93-109. [PMID: 29279605 DOI: 10.1038/nrg.2017.96] [Cited by in Crossref: 104] [Cited by in F6Publishing: 90] [Article Influence: 20.8] [Reference Citation Analysis]
53 Ahmed AA, Vundamati DS, Farooqi MS, Guest E. Precision Medicine in Pediatric Cancer: Current Applications and Future Prospects. High Throughput 2018;7:E39. [PMID: 30551569 DOI: 10.3390/ht7040039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
54 Mardis ER. The Impact of Next-Generation Sequencing on Cancer Genomics: From Discovery to Clinic. Cold Spring Harb Perspect Med 2019;9:a036269. [PMID: 30397020 DOI: 10.1101/cshperspect.a036269] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
55 Klco JM, Mullighan CG. Advances in germline predisposition to acute leukaemias and myeloid neoplasms. Nat Rev Cancer 2021;21:122-37. [PMID: 33328584 DOI: 10.1038/s41568-020-00315-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
56 Gargallo P, Juan A, Yáñez Y, Dolz S, Segura V, Castel V, Cañete A. Precision medicine in Ewing sarcoma: a translational point of view. Clin Transl Oncol 2020;22:1440-54. [PMID: 32026343 DOI: 10.1007/s12094-020-02298-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
57 Siraj AK, Masoodi T, Bu R, Parvathareddy SK, Siraj S, Alassiri A, Al-Dayel F, Alkuraya FS, Al-Kuraya KS. The study of Lynch syndrome in a special population reveals a strong founder effect and an unusual mutational mechanism in familial adenomatous polyposis. Gut 2020;69:2048-9. [PMID: 31924657 DOI: 10.1136/gutjnl-2019-320511] [Reference Citation Analysis]
58 Grey VL, Loh TP, Metz M, Lang T, Hersberger M. Paediatric Laboratory Medicine - Some reflections on the sub-specialty. Clin Biochem 2017;50:648-50. [PMID: 28410851 DOI: 10.1016/j.clinbiochem.2017.04.005] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
59 Okur V, Chung WK. The impact of hereditary cancer gene panels on clinical care and lessons learned. Cold Spring Harb Mol Case Stud 2017;3:a002154. [PMID: 29162654 DOI: 10.1101/mcs.a002154] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
60 Gargallo P, Yáñez Y, Juan A, Segura V, Balaguer J, Torres B, Oltra S, Castel V, Cañete A. Review: Ewing Sarcoma Predisposition. Pathol Oncol Res 2020;26:2057-66. [PMID: 31656020 DOI: 10.1007/s12253-019-00765-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
61 Swilling A, Pham R, Wang J, Vallance K, Hamby T, Ray A. Lessons Learned: Utilization of a Reference Laboratory for Targeted Sequencing of Pediatric Tumors at a Single Institution. J Pediatr Hematol Oncol 2022. [PMID: 35537075 DOI: 10.1097/MPH.0000000000002485] [Reference Citation Analysis]
62 Kraft IL, Godley LA. Identifying potential germline variants from sequencing hematopoietic malignancies. Blood 2020;136:2498-506. [PMID: 33236764 DOI: 10.1182/blood.2020006910] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Hertz DL, Glatz A, Pasternak AL, Lonigro RJ, Vats P, Wu YM, Anderson B, Rabban E, Mora E, Frank K, Robinson DR, Mody RJ, Chinnaiyan A. Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program. JCO Precis Oncol 2018;2. [PMID: 32832831 DOI: 10.1200/po.18.00011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
64 Vivian J, Eizenga JM, Beale HC, Vaske OM, Paten B. Bayesian Framework for Detecting Gene Expression Outliers in Individual Samples. JCO Clin Cancer Inform 2020;4:160-70. [PMID: 32097024 DOI: 10.1200/CCI.19.00095] [Reference Citation Analysis]
65 Ampe C, Witjes L, Van Troys M. Cancer type-specific alterations in actin genes: Worth a closer look? Int Rev Cell Mol Biol 2021;360:133-84. [PMID: 33962749 DOI: 10.1016/bs.ircmb.2021.02.017] [Reference Citation Analysis]
66 Tsoli M, Wadham C, Pinese M, Failes T, Joshi S, Mould E, Yin JX, Gayevskiy V, Kumar A, Kaplan W, Ekert PG, Saletta F, Franshaw L, Liu J, Gifford A, Weber MA, Rodriguez M, Cohn RJ, Arndt G, Tyrrell V, Haber M, Trahair T, Marshall GM, McDonald K, Cowley MJ, Ziegler DS. Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer. Cancer Biol Ther 2018;19:1078-87. [PMID: 30299205 DOI: 10.1080/15384047.2018.1491498] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
67 Venier RE, Grubs RE, Kessler E, Cooper KL, Bailey KM, Meade J. Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States. Journal of Genetic Counseling. [DOI: 10.1002/jgc4.1559] [Reference Citation Analysis]
68 Niguidula N, Alamillo C, Shahmirzadi Mowlavi L, Powis Z, Cohen JS, Farwell Hagman KD. Clinical whole-exome sequencing results impact medical management. Mol Genet Genomic Med 2018;6:1068-78. [PMID: 30318729 DOI: 10.1002/mgg3.484] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
69 Tsui PC, Lee YF, Liu ZWY, Ip LRH, Piao W, Chiang AKS, Lui VWY. An update on genomic-guided therapies for pediatric solid tumors. Future Oncol 2017;13:1345-58. [PMID: 28589766 DOI: 10.2217/fon-2017-0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Tan O, Shrestha R, Cunich M, Schofield D. Application of next-generation sequencing to improve cancer management: A review of the clinical effectiveness and cost-effectiveness. Clin Genet 2018;93:533-44. [DOI: 10.1111/cge.13199] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
71 Zanazzi G, Liechty BL, Pendrick D, Krasnozhen-Ratush O, Snuderl M, Allen JC, Garvin JH, Mansukhani MM, Roth KA, Hsiao SJ. Diffuse midline glioma with novel, potentially targetable, FGFR2-VPS35 fusion. Cold Spring Harb Mol Case Stud 2020;6:a005660. [PMID: 32839179 DOI: 10.1101/mcs.a005660] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Goudie C, Cullinan N, Villani A, Mathews N, van Engelen K, Malkin D, Irwin MS, Foulkes WD. Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors. Pediatr Blood Cancer 2018;65:e27390. [DOI: 10.1002/pbc.27390] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
73 Olson N, Rouhi O, Zhang L, Angeles C, Bridge J, Lopez-Terrada D, Royce T, Linos K. A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4-NTRK3 fusion. J Cutan Pathol 2018;45:933-9. [PMID: 30175468 DOI: 10.1111/cup.13348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
74 Peters SM, Turk AT. Salivary gland anlage tumor: molecular profiling sheds light on a morphologic question. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:e108-13. [PMID: 30598408 DOI: 10.1016/j.oooo.2018.11.010] [Reference Citation Analysis]
75 Surrey LF, MacFarland SP, Chang F, Cao K, Rathi KS, Akgumus GT, Gallo D, Lin F, Gleason A, Raman P, Aplenc R, Bagatell R, Minturn J, Mosse Y, Santi M, Tasian SK, Waanders AJ, Sarmady M, Maris JM, Hunger SP, Li MM. Clinical utility of custom-designed NGS panel testing in pediatric tumors. Genome Med 2019;11:32. [PMID: 31133068 DOI: 10.1186/s13073-019-0644-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]